Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TMEM164 | FIMM | pan-cancer | AAC | 0.46 | 0.007 |
mRNA | MISP3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
mRNA | HACD2 | CCLE | pan-cancer | AAC | 0.15 | 0.007 |
mRNA | JAZF1 | CCLE | pan-cancer | AAC | -0.14 | 0.007 |
mRNA | MAP1B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
mRNA | ZMYND10 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |
mRNA | TMEM139 | CCLE | pan-cancer | AAC | 0.16 | 0.007 |
mRNA | U2AF1L5 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
mRNA | DNAJC18 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
mRNA | DUOXA1 | CCLE | pan-cancer | AAC | 0.14 | 0.007 |